243 studies found for:    Exclude Unknown | Expanded Access Studies
Show Display Options
Rank Status Study
21 Approved for marketing Mentor Adjunct Study for Silicone Gel-Filled Mammary Prosthesis
Condition: Breast Reconstruction
Intervention: Device: Silicone Gel-Filled Mammary Prostheses
22 Available 18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia
Conditions: Congenital Hyperinsulinism;   Beckwith-Wiedemann Syndrome;   Insulinoma
Intervention: Drug: 18F-DOPA
23 No longer available Expanded Access Multicenter Study of Lucanix® (Belagenpumatucel-L)
Condition: Non-small Cell Lung Cancer
Intervention: Biological: Lucanix® (belagenpumatucel-L)
24 Approved for marketing Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced Heart Disease
Condition: Iron Overload
Intervention: Drug: deferiprone
25 Approved for marketing Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Active Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Biological: adalimumab
26 Approved for marketing Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patients With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Pomalidomide
27 Available Expanded Access Program: Safety of Erythrocytes Encapsulating L-asparaginase (GRASPA®) in Combination With Polychemotherapy in Patients Under 55 Years Old With Acute Lymphoblastic Leukemia (ALL) at Risk to Receive Other Formulation of Asparaginase
Condition: Acute Lymphoblastic Leukemia
Intervention: Drug: suspension of erythrocytes encapsulating L-asparaginase
28 Available Compassionate Use of the Incraft® AAA Stent Graft System
Condition: Abdominal Aortic Aneurysm
Intervention: Device: Endovascular AAA repair
29 Available Magnetic Resonance-guided High-intensity Focused Ultrasound Treatment of Locally Advanced Pancreatic Cancer
Conditions: Pancreas;   Cancer;   Locally Advanced Pancreatic Cancer;   Non-invasive Treatment
Intervention: Procedure: Magnetic Resonance-guided High-intensity Focused Ultrasound (MRgFUS)
30 No longer available LUX Lung Special Access Scheme Australia Named Patient Use (NPU)
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: BIBW 2992
31 Temporarily not available Development of a Fall Prevention and Fall Detection System for Ambulatory Rehabilitation of Parkinson's Patients
Condition: Parkinson's Disease
Intervention: Other: portable motion detector
32 Approved for marketing A Study of Vismodegib (GDC-0449) in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
Condition: Basal Cell Carcinoma
Intervention: Drug: Vismodegib (GDC-0449)
33 Available Compassionate Use Protocol for the Treatment of Autoinflammatory Syndromes
Conditions: Chronic Atypical Neutrophilic Dermatosis With Lipodystrophy and Elevated Temperature (CANDLE);   Juvenile Dermatomyositis (JDM);   Stimulator of Interferon Genes (STING)-Associated Vasculitis With Onset in Infancy (SAVI)
Intervention: Drug: Baricitinib
34 Available Regorafenib in Subjects With Metastatic Colorectal Cancer (CRC) Who Have Progressed After Standard Therapy
Condition: Colorectal Neoplasms
Intervention: Drug: Regorafenib (BAY73-4506)
35 No longer available Compassionate Use of Metvix® (Methyl Aminolevulinate) Photodynamic Therapy (PDT) in Subjects With Field Actinic Keratoses, Large/Multiple Superficial Basal Cell Carcinomas (BCCs), or Bowen's Disease
Conditions: Field Actinic Keratoses;   Basal Cell Carcinoma;   Bowen's Disease
Intervention: Drug: Metvix (methyl aminolevulinate)
36 Temporarily not available Standardization Research of TCM Syndrome Differentiation and Treatment on Advanced Breast Cancer
Conditions: Breast Cancer;   Bone Metastasis
Intervention: Dietary Supplement: Chinese Herbs
37 Approved for marketing An Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients With Lamivudine-Resistant Chronic Hepatitis B With Limited Treatment Options
Condition: Chronic Hepatitis B
Intervention: Drug: Adefovir Dipivoxil
38 No longer available Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: Regorafenib (BAY73-4506)
39 No longer available Treatment Use Study for Advanced Melanoma.
Condition: Advanced Unresectable Melanoma
Intervention: Drug: CP-675,206
40 Approved for marketing An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Interventions: Drug: Obinutuzumab;   Drug: Chlorambucil

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years